Come together to transform the future of breast cancer this October

Developing a vaccine to treat triple negative breast cancer

Dr Lee-Hwa Tai is pioneering a unique immunotherapy approach for treating one of the most challenging forms of breast cancer.

Charity Partner

Canadian Cancer Society
Canadian Cancer Society
Toronto, Canada

Research Institute

Université de Sherbrooke
Université de Sherbrooke
Sherbrooke, Canada


Dr Lee-Hwa  Tai, PhD

Dr Lee-Hwa Tai, PhD

Latest Activity

Why should you donate to this project?

1 in 8 Canadian women are expected to be diagnosed with breast cancer in their lifetime. That's 27,900 women every year, with thousands more living with the disease.

A researcher with a solution:

Dr Lee-Hwa Tai, an esteemed researcher with expertise in immunotherapy, is developing a vaccine to target the difficult-to-treat triple negative breast cancer. Learn more about the team >

A personalized approach to immunotherapy.

Personalized immunotherapy designs vaccines based on the unique characteristics of an individual’s cancer cells. This approach offers a more specialized and stronger treatment, especially for those who often don't respond to conventional therapies. Learn more about the research >

Explore more projects from Canadian Cancer Society

View projects